Osaic Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$287K Buy
208
+206
+10,300% +$209K ﹤0.01% 3840
2025
Q4
$79.7K Buy
2
+1
+100% +$956 ﹤0.01% 4893
2025
Q3
$19.2K Hold
1
﹤0.01% 5956
2025
Q2
$24.8K Hold
1
﹤0.01% 5546
2025
Q1
$30.1K Hold
1
﹤0.01% 5077
2024
Q4
$47.7K Sell
1
-2
-67% -$1.66K ﹤0.01% 4743
2024
Q3
$39.8K Hold
3
﹤0.01% 4903
2024
Q2
$42.4K Hold
3
﹤0.01% 4807
2024
Q1
$31.6K Buy
+3
New +$2.13K ﹤0.01% 5067
2023
Q4
Sell
-1
Closed -$24.3K 7393
2023
Q3
$24.3K Hold
1
﹤0.01% 5444
2023
Q2
$17.7K Hold
1
﹤0.01% 5653
2023
Q1
$6.55K Buy
+1
New +$337 ﹤0.01% 6210

Other funds holding LLY

Osaic Holdings's LLY Position: Q1 2026 in Review

Osaic Holdings increased its Eli Lilly (LLY) stake by 8.6% in Q1 2026, buying an estimated $25M and bringing the position to 312,761 shares worth $288M. The position accounts for 0.42% of the portfolio, ranked #34.

Osaic Holdings first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $310M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Osaic Holdings held 312,761 shares of Eli Lilly worth $288M as of Q1 2026.
  • Osaic Holdings bought 24,644 Eli Lilly shares in Q1 2026, an estimated $25M.
  • Eli Lilly made up 0.42% of Osaic Holdings's portfolio in Q1 2026, its #34 holding.
  • Osaic Holdings first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Eli Lilly position peaked at $310M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.